Eaton Vance Management Red Hill Biopharma Ltd. Transaction History

Eaton Vance Management

  • $67.5 Billion
  • Q3 2022

A detailed history of Eaton Vance Management transactions in Red Hill Biopharma Ltd. stock. As of the latest transaction made, Eaton Vance Management holds 40,417 shares of RDHL stock, worth $294,639. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,417
Previous 40,417 -0.0%
Holding current value
$294,639
Previous $35,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$1.65 - $3.12 $3,300 - $6,240
2,000 Added 5.21%
40,417 $102,000
Q3 2021

Nov 15, 2021
BUY
$4.55 - $10.36 $174,797 - $398,000
38,417 New
38,417 $176,000

Others Institutions Holding RDHL

# of Institutions
2
Shares Held
40.4K
Call Options Held
0
Put Options Held
0
View Full List

About RedHill Biopharma Ltd.

RDHL Quotes by TradingView
  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $465M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email